Skip to main content
رجوع
Watch Compare

Glucose Health, Inc.

جودة البيانات: 100%
GLUC
OTC Manufacturing Chemicals
KWD 0.44
▲ KWD 0.04 (10.75%)
القيمة السوقية: 7.71 M
السعر
KWD 0.44
القيمة السوقية
7.71 M
نطاق اليوم
KWD 0.40 — KWD 0.47
نطاق 52 أسبوعًا
KWD 0.02 — KWD 0.67
حجم التداول
13,103
فتح KWD 0.47
متوسط 50 يوم / 200 يوم
KWD 0.33
36.22% above
متوسط 50 يوم / 200 يوم
KWD 0.18
149.58% above

Quick Summary

النقاط الرئيسية

Negative free cash flow of -17,253.0

النمو

Revenue Growth (5Y)
N/A
Revenue (1Y)7232.14%
Earnings (1Y)N/A
FCF Growth (3Y)N/A

الجودة

Return on Equity
N/A
ROICN/A
Net Margin-96.52%
Op. Margin-36.82%

الأمان

Debt / Equity
N/A
Current Ratio0.06
Interest Coverage-0.29

التقييم

PE (TTM)
-90.68
أقل من متوسط القطاع (-1.98)
P/B RatioN/A
EV/EBITDAN/A
Dividend YieldN/A

تاريخ السعر

الاتجاهات المالية

مقارنة الأقران

مقابل وسيط قطاع Manufacturing (44 نظير)
المقياس السهم وسيط القطاع
P/E -90.7 -2.0
P/B — 5.1
ROE % — -51.0
Net Margin % -96.5 -150.2
Rev Growth 5Y % — 9.3
D/E — 0.3

All Fundamental Metrics
Growth
Revenue Growth (1Y) 7232.14% Revenue Growth (3Y) 969.39%
Earnings Growth (1Y) N/A Earnings Growth (3Y) N/A
Revenue Growth (5Y) N/A Earnings Growth (5Y) N/A
Profitability
Revenue (TTM) 88,130.0 Net Income (TTM) -85,062.0
ROE N/A ROA -316.98%
Gross Margin 65.39% Operating Margin -36.82%
Net Margin -96.52% Free Cash Flow (TTM) -17,253.0
ROIC N/A FCF Growth (3Y) N/A
Safety
Debt / Equity N/A Current Ratio 0.06
Interest Coverage -0.29 Asset Turnover 3.28
Working Capital -426,427 Tangible Book Value -426,232
Dividends
Dividend Yield N/A Payout Ratio N/A
Dividend Growth (3Y) N/A Dividend Growth (5Y) N/A
Consecutive Div Years N/A
Valuation
P/E Ratio -90.68 Forward P/E N/A
P/B Ratio N/A P/S Ratio 87.52
PEG Ratio N/A Forward PEG N/A
EV/EBITDA N/A Fwd EV/EBITDA N/A
Forward P/S N/A Fwd Earnings Yield N/A
FCF Yield -0.22%
Market Cap 7.71 M Enterprise Value 7.70 M
Per Share
EPS (Diluted TTM) N/A Revenue / Share 0.01
FCF / Share 0.00 OCF / Share 0.00
EPS CAGR (1Y) N/A EPS CAGR (5Y) N/A
EPS CAGR (10Y) N/A
Efficiency
CapEx / Revenue N/A FCF Conversion 20.28%
SBC-Adj. FCF -18,159 Growth Momentum N/A

Income Statement

Annual, most recent first
Metric FY2016 FY2015 FY2014 FY2013 FY2012
Revenue 313,229.0 4,272.0 2,739.0 -224.0 —
Net Income -410,443.0 -266,064.0 -669,409.0 -2.03 M -568,650.0
EPS (Diluted) — — — — —
Gross Profit 19,167.0 397.0 -20,725.0 -5,723.0 -3,632.0
Operating Income -86,647.0 -156,173.0 -545,216.0 -1.80 M -532,479.0
EBITDA — — — — —
R&D Expenses 48.0 48.0 4,000.0 — —
SG&A Expenses — — — — —
D&A — — — — —
Interest Expense 323,796.0 120,028.0 109,631.0 205,033.0 36,171.0
Income Tax — — — — —

Balance Sheet

Annual, most recent first
Metric FY2016 FY2015 FY2014 FY2013 FY2012
Total Assets 33,145.0 15,407.0 44,030.0 25,590.0 207,676.0
Total Liabilities 528,592.0 403,226.0 324,582.0 223,348.0 185,476.0
Shareholders' Equity -495,447.0 -387,819.0 -280,552.0 -197,758.0 22,200.0
Total Debt — — — — —
Cash & Equivalents 20,542.0 2,055.0 711.0 1,076.0 82.0
Current Assets 32,905.0 15,107.0 43,730.0 25,590.0 1,076.0
Current Liabilities 528,592.0 403,226.0 324,582.0 223,348.0 185,476.0